HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lu Gao Selected Research

Rafoxanide

2/2020Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.
1/2019Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lu Gao Research Topics

Disease

75Neoplasms (Cancer)
02/2022 - 08/2008
22Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2013
20Infections
06/2022 - 05/2006
19Inflammation (Inflammations)
01/2022 - 07/2011
18Hepatocellular Carcinoma (Hepatoma)
02/2022 - 11/2009
18Fibrosis (Cirrhosis)
10/2021 - 02/2014
16Multiple Myeloma
05/2022 - 01/2014
16Hypertrophy
05/2022 - 12/2013
14Acromegaly
01/2022 - 05/2017
12Hypoxia (Hypoxemia)
01/2022 - 11/2009
10Carcinogenesis
01/2022 - 04/2014
9Heart Failure
01/2022 - 12/2013
8Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 04/2008
6Pituitary Neoplasms (Pituitary Adenoma)
11/2021 - 01/2019
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 03/2015
6Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2019
6Neoplasm Metastasis (Metastasis)
01/2020 - 05/2014
6Diabetes Mellitus
05/2019 - 11/2008
5Obesity
05/2022 - 05/2014
5Thrombosis (Thrombus)
01/2020 - 09/2011
5Acute Kidney Injury (Acute Renal Failure)
11/2019 - 03/2017
5Vascular System Injuries
05/2019 - 04/2012
5Neointima
04/2015 - 04/2012
4Glioma (Gliomas)
06/2022 - 04/2014
4Cerebral Hemorrhage
07/2020 - 03/2014
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2020 - 11/2016
4Ischemia
01/2020 - 09/2015
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 11/2016
4Squamous Cell Carcinoma of Head and Neck
01/2020 - 12/2016
4Critical Illness (Critically Ill)
11/2019 - 03/2017
4Growth Hormone-Secreting Pituitary Adenoma
02/2019 - 02/2016
4Chronic Hepatitis B
01/2019 - 01/2018
4Insulin Resistance
01/2019 - 03/2014
4Asthma (Bronchial Asthma)
01/2019 - 10/2009
4Infarction (Infarctions)
01/2019 - 02/2015
3Breast Neoplasms (Breast Cancer)
01/2022 - 11/2014
3Esophageal Squamous Cell Carcinoma
05/2021 - 11/2015
3Liver Neoplasms (Liver Cancer)
01/2021 - 10/2018
3Non-alcoholic Fatty Liver Disease
01/2021 - 01/2017
3Hypersensitivity (Allergy)
11/2020 - 12/2019
3Colitis
10/2020 - 01/2020
3T-Cell Leukemia (Leukemia, T Cell)
06/2020 - 06/2014
3Cardiotoxicity
02/2020 - 08/2018
3Pituitary ACTH Hypersecretion
01/2020 - 02/2017
3Pre-Eclampsia (Preeclampsia)
01/2020 - 03/2016
3Adenoma (Adenomas)
01/2020 - 04/2019
3Virus Diseases (Viral Diseases)
01/2020 - 01/2013

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2011
14Glucose (Dextrose)FDA LinkGeneric
05/2022 - 02/2008
13Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2014
12Angiotensin IIIBA
01/2021 - 12/2013
12Insulin-Like Growth Factor I (IGF-1)IBA
03/2020 - 02/2016
11Messenger RNA (mRNA)IBA
06/2022 - 05/2007
11CytokinesIBA
02/2022 - 07/2011
10Pharmaceutical PreparationsIBA
10/2021 - 08/2012
8Hormones (Hormone)IBA
01/2022 - 04/2017
8Small Interfering RNA (siRNA)IBA
01/2019 - 11/2009
7MicroRNAs (MicroRNA)IBA
02/2022 - 01/2014
7Biological ProductsIBA
03/2021 - 01/2013
7Long Noncoding RNAIBA
01/2021 - 01/2017
7Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2016
7Growth Hormone (Somatotropin)IBA
01/2020 - 02/2016
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 08/2011
5Antiviral Agents (Antivirals)IBA
11/2020 - 01/2018
5Phosphotransferases (Kinase)IBA
11/2020 - 05/2015
5Hydrocortisone (Cortisol)FDA LinkGeneric
01/2020 - 05/2006
5LipopolysaccharidesIBA
01/2020 - 08/2012
4Therapeutic UsesIBA
03/2021 - 08/2018
4CreatinineIBA
03/2021 - 03/2017
4Adenosine Triphosphate (ATP)IBA
03/2021 - 01/2012
4LipidsIBA
01/2021 - 03/2014
4InterferonsIBA
01/2021 - 01/2016
4Sirtuin 1IBA
01/2020 - 09/2014
4Histone Deacetylase InhibitorsIBA
01/2020 - 06/2014
4pterostilbeneIBA
05/2019 - 11/2016
4Streptozocin (Streptozotocin)FDA Link
05/2019 - 01/2019
4theasinensin AIBA
03/2019 - 03/2013
4Blood Glucose (Blood Sugar)IBA
01/2019 - 02/2016
4Insulin (Novolin)FDA Link
01/2019 - 08/2018
4Carbon Tetrachloride (Tetrachloromethane)IBA
06/2016 - 01/2015
3Capsules (Microcapsules)IBA
04/2022 - 02/2014
3Dextran SulfateIBA
04/2022 - 01/2020
3Diethylnitrosamine (N-Nitrosodiethylamine)IBA
02/2022 - 12/2016
3Oxygen (Dioxygen)IBA
01/2022 - 11/2015
3ProlactinIBA
07/2021 - 08/2019
3Hexosaminidases (Hexosaminidase)IBA
03/2021 - 03/2017
3Competitive Endogenous RNAIBA
01/2021 - 01/2019
3Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2011
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
3DCZ3301IBA
06/2020 - 01/2017
3PanobinostatIBA
01/2020 - 01/2015
3Cystatin CIBA
11/2019 - 03/2017
3Becaplermin (PDGF-BB)FDA Link
01/2019 - 04/2012
3Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2018 - 02/2014

Therapy/Procedure

26Therapeutics
01/2022 - 08/2011
7Drug Therapy (Chemotherapy)
01/2022 - 08/2008
7Immunotherapy
03/2021 - 01/2020
6Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2020 - 10/2009
5Radiotherapy
01/2021 - 08/2008
3Intraperitoneal Injections
02/2020 - 10/2017